Posts

Showing posts with the label Bioburden Monitoring
Loading pharmaceutical microbiology articles...
Established 2017 · Professional Knowledge Platform

Pharmaceutical Microbiology Knowledge & Regulatory Intelligence

Explore pharmaceutical microbiology, global GMP regulatory guidance, sterility assurance, microbiology testing, environmental monitoring and professional certification resources for students and industry professionals.

Featured Knowledge Centres

Regulatory Guidance & Standards Centre

Explore all →

Featured Technical Resource Centre

Explore topics →

Microbiology Testing Centre

Explore testing →

Aseptic Processing & Cleanroom

Explore topics →

GMP & Quality Management System

Explore topics →

Professional Resources

Explore resources →

PMCC Certification Centre

View courses →

Latest Pharma Job Hub

💼

Pharmaceutical Industry Career Opportunities

Explore pharmaceutical microbiology, QC, QA, production, validation and regulatory affairs vacancies.

Visit Latest Pharma Job Hub →

Business Support & Industry Partnerships

Policy & Information Centre

Advance Your Pharmaceutical Microbiology Knowledge

Practical technical knowledge, international regulatory intelligence and professional learning resources for the pharmaceutical industry.

Explore Knowledge Centre →

USP 1119 and 1119.1 Bioburden Testing: GMP Guide 2026

Image
USP <1119> & <1119.1> Bioburden Testing: GMP Guide 2026 🚨 Inspection Warning: A bioburden result by itself does not prove that a process is under control. During a GMP inspection, the deeper questions are often: Why was this sample point selected? Why this sample quantity? Why this method? Was recovery demonstrated? Was the result trended? What happened when the control failed? Bioburden testing is therefore not simply a microbiological enumeration exercise. It is a critical element of the pharmaceutical microbial contamination control strategy. USP <1119> places strong emphasis on a risk-based bioburden monitoring program , while USP <1119.1> provides the companion test methodology for quantitative enumeration. Quick Answer: What Changed in the Practical Approach? USP <1119>: Focuses on where, when, how much and why bioburden samples are collected, including risk assessment, sampling points, frequency, quantities, acceptance cr...